







 
 
  







<HTML>
<HEAD>
<TITLE>JBC --  Hansen et al. 275 (29): 22381</TITLE>


	<SCRIPT LANGUAGE="JavaScript">
	<!--
	function startTarget(windowname,wid,hei) {
	
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1)
	{
	var tempwn = windowname.substring(0,dotpos) +
		windowname.substring(dotpos + 1, windowname.length);
	windowname = tempwn;
	}
	var sizestring = 'width=' + wid + ',height=' + hei;
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');
	}
	// -->
	</SCRIPT>



	<!-- has inhead tag -->
	 
	 
	<script language="JavaScript">
	<!--
	if ( top != self )
	{
		top.location.href = unescape(window.location.pathname);
	}
	//-->
	</script>
	
	

<meta name="robots" content="nofollow">
</HEAD>
<BODY BGCOLOR="#FFFFFF" 
	
		
			
		
	>



<A NAME="top"><!-- null --></A>

	
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
	<TR>
		<TD VALIGN="BOTTOM" NOWRAP>
			<A TARGET="_top" STYLE="text-decoration: none" HREF="/"><IMG BORDER="0" WIDTH="220" HEIGHT="44" ALT="JBC" SRC="/icons/banner/title.gif"></A>
			<A TARGET="_top" HREF="/cgi/adclick?journal=jbc&ad=Biosource%20banner&url=http://www.biosource.com&side=only"><IMG BORDER=2 WIDTH=220 HEIGHT=40 SRC="/ads/gifs/1052416975.gif" ALT="Biosource"></A><BR><IMG ALT="" WIDTH="1" HEIGHT="3" SRC="/icons/spacer.gif"><BR>
			
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol275/issue29/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	</TD>
		<TD><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
		<TD VALIGN="BOTTOM">
	
	<TABLE CELLPADDING="0" CELLSPACING="1" BORDER="0" BGCOLOR="#000000"><TR>
	<FORM METHOD="GET" NAME="search" ACTION="/cgi/search"><INPUT TYPE="hidden" NAME="andorexactfulltext" VALUE="and"><INPUT TYPE="hidden" NAME="resourcetype" VALUE="1"><INPUT TYPE="hidden" NAME="disp_type" VALUE="">
	<TD ALIGN="CENTER" VALIGN="MIDDLE"> 
		<TABLE CELLPADDING="1" CELLSPACING="0" BORDER="0" BGCOLOR="#DBDBDB"> 
		<TR>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD VALIGN="MIDDLE"  BGCOLOR="#006699" NOWRAP><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#FFFFFF"><EM>QUICK</EM> SEARCH:&nbsp;</FONT></STRONG></TD>
			<TD ALIGN="RIGHT" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A STYLE="text-decoration:none;color:#FFFFFF" HREF="/search.dtl"><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">&nbsp;[advanced]</FONT></A></TD>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR><TR>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD BGCOLOR="#DBDBDB" COLSPAN="2">
			<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0"> 
			<TR>
				<TD ALIGN="CENTER" VALIGN="BOTTOM"><INPUT TYPE="submit" STYLE="text-decoration:none;font-family:verdana,arial,helvetica;font-size:10px;font-weight:bold;color:#000000;background:#FFFFFF;" VALUE="Go"></TD>
				<TH ALIGN="LEFT" COLSPAN="2"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Author:<BR></FONT>
					<INPUT TYPE="text" NAME="author1" SIZE="9" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
				<TH ALIGN="LEFT" COLSPAN="3"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Keyword(s):<BR></FONT>
					<INPUT TYPE="text" NAME="fulltext" SIZE="16" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
			</TR><TR>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Year:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="pubdate_year" SIZE="4" MAXLENGTH="4" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH ALIGN="RIGHT"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Vol:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="volume" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Page:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="firstpage" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
			</TR> 
			</TABLE> </TD>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR>
		</TABLE></TD></FORM></TR></TABLE> 
	 
	</TD>
	</TR><TR>
		<TD COLSPAN="3"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"><BR>







	
	

	




	


	
	
	
	 

	


	
	




				<BR><FONT SIZE="-2" FACE="verdana,arial,helvetica">
	<NOBR><STRONG>Institution: Cornell University Medical College</STRONG></NOBR>
	<NOBR><A TARGET="_top" HREF="/cgi/login?uri=%2Fcgi%2Fcontent%2Ffull%2F275%2F29%2F22381">Sign In as Member/Non-Member</A></NOBR>
	
		
		
	
	</FONT>
	
 <!-- showauthstring -->
	<!-- INST -->
	<!-- INDV -->
        <!-- SPONSORED -->
	<!-- USER.PFA -->
	<!-- USER.PFABSAIC -->
	<!-- NOT GUEST -->
	

	
<HR ALIGN="LEFT" SIZE="1" COLOR="#000000" NOSHADE></TD>
	</TR>
	</TABLE>
	



         
                
        



	
		
		
	 
 




		<FONT COLOR="#A70716"></FONT>
	
	<FONT SIZE=-1>Originally published In Press as  <A HREF="/cgi/content/abstract/M001946200v1">doi:10.1074/jbc.M001946200</A> on April 11, 2000</FONT>


	
		
		<P><FONT SIZE=-1>J. Biol. Chem., Vol. 275, Issue 29, 22381-22386, July 21, 2000</FONT><BR>
		
	

 

 
	  
		                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/275/29/22381">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/275/29/22381">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;275/29/22381">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/275/29/22381&title=Transgenic+Overexpression+of+Hexokinase+II+in+Skeletal+Muscle+Does+Not+Increase+Glucose+Disposal+in+Wild-type+or+Glut1-overexpressing+Mice">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;M001946200&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=10764781&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=10764781&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		
		<TR><TD><FONT SIZE="-1">
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="#otherarticles">other online articles</A>
		</FONT></TD></TR>
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Hansen+PA&link_type=AUTHORSEARCH">Hansen, P. A.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Mueckler+M&link_type=AUTHORSEARCH">Mueckler, M.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;275/29/22381&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F275%2F29%2F22381"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;275/29/22381">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx --><!-- 4xxx --><!-- 5xxx -->         
	        <TR><TD ALIGN=LEFT NOWRAP>   <!-- revisions table -->
		

	
	<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
	All Versions of this Article:	
	</FONT></TD></TR>
	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">275/29/22381<FONT COLOR="#A70716"> (most recent)</FONT></FONT></TD></TR>
	         

	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/content/short/M001946200v1">M001946200v1</A></FONT></TD></TR>
	
	</TABLE>
	         

    
		</TD></TR>
        
        
	</TABLE>	 <!-- end of outer content box -->
	


	









 





	
	
	
	
	
	
	
	
	
		<vardef id="TEXT">

<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->





<H2>
<FONT COLOR=A70716 SIZE=-1>

</FONT>

    Transgenic Overexpression of Hexokinase II in Skeletal  Muscle
Does Not Increase Glucose Disposal in Wild-type  or
Glut1-overexpressing Mice<A HREF="#FN150"><SUP>*</SUP></A>
    <BR>


</H2>



<STRONG>
<NOWRAP>
Polly A. 
Hansen<SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP><A HREF="#FN153"><SUP>&#167;</SUP></A>,<WBR>
Bess Adkins 
Marshall<A HREF="#FN153"><SUP>&#167;</SUP></A><SUP>&#182;</SUP>,<WBR>
May 
Chen<SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP>,<WBR>
John O. 
Holloszy<SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP>, and<WBR>
Mike 
Mueckler<SUP><IMG SRC="/math/12pt/normal/scr/par.gif" ALIGN=BASELINE ALT="||"></SUP><A HREF="#FN160"><SUP>**</SUP></A>
</NOWRAP>
</STRONG>
<P>
From the Departments of <SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP>&nbsp;Medicine, <SUP>&#182;</SUP>&nbsp;Pediatrics,
and <SUP><IMG SRC="/math/12pt/normal/scr/par.gif" ALIGN=BASELINE ALT="||"></SUP>&nbsp;Cell Biology and Physiology, Washington University
School of Medicine, St. Louis, Missouri 63110
<P>
Received for publication, March 9,&nbsp;2000, and in revised form, March 30,&nbsp;2000
<P>






    
	
	    
	
	    
		
    
	
	    
	
    
	
	    
	
    
    
	
	    
	
    







<a name = "Abstract"><!-- comment for mosaic --></a>



<A NAME="Abstract"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABSTRACT</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>ABSTRACT</FONT>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

<P>Glut1 transgenic mice were bred with transgenic
mice that overexpress hexokinase II in skeletal muscle in order to
determine<SUP> </SUP>whether whole-body glucose disposal could be further
augmented<SUP> </SUP>in mice overexpressing glucose transporters. Overexpression
of<SUP> </SUP>hexokinase alone in skeletal muscle had no effect on glucose
transport<SUP> </SUP>or metabolism in isolated muscles, nor did it alter blood
glucose<SUP> </SUP>levels or the rate of whole-body glucose disposal. Expression<SUP> </SUP>of the hexokinase transgene in the context of the Glut1 transgenic<SUP> </SUP>background did not alter glucose transport in isolated muscles<SUP> </SUP>but did
cause additional increases in steady-state glucose 6-phosphate<SUP> </SUP>(3.2-fold) and glycogen (7.5-fold) levels compared with muscles<SUP> </SUP>that
overexpress the Glut1 transporter alone. Surprisingly, however,<SUP> </SUP>these
increases were not accompanied by a change in basal or
insulin-stimulated<SUP> </SUP>whole-body glucose disposal in the doubly transgenic
mice compared<SUP> </SUP>with Glut1 transgenic mice, probably due to an inhibition
of <I>de<SUP> </SUP>novo</I> glycogen synthesis as a result of the high
levels of steady-state<SUP> </SUP>glycogen in the muscles of doubly transgenic
mice (430&nbsp;&#181;mol/g<SUP> </SUP><I>versus</I> 10&nbsp;&#181;mol/g in wild-type mice).
We conclude that the hexokinase<SUP> </SUP>gene may not be a good target for
therapies designed to counteract<SUP> </SUP>insulin resistance or<SUP> </SUP>hyperglycemia.
<BR><BR CLEAR=ALL>




<TXT>
<A NAME="SEC0"><!-- comment for mosaic --></A>

    
    

    
    

    
    
	
	
	
<A NAME="Introduction"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;INTRODUCTION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>INTRODUCTION</FONT>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

    

<P>Transgenic mice that overexpress the Glut1 glucose transporter in
skeletal muscle have been extensively characterized. Muscles<SUP> </SUP>isolated
from these mice exhibit a dramatic increase in basal<SUP> </SUP>glucose transport
and basal glucose metabolism (<A HREF="#B1">1</A>, <A HREF="#B2">2</A>). The<SUP> </SUP>Glut1-overexpressing mice are
hypoglycemic relative to non-transgenic<SUP> </SUP>littermates and demonstrate an
elevation in whole-body glucose<SUP> </SUP>disposal under both basal and
euglycemic/hyperinsulinemic clamp<SUP> </SUP>conditions (<A HREF="#B1">1</A>, <A HREF="#B3">3</A>). These observations
demonstrate that transport<SUP> </SUP>is rate-limiting for muscle glucose
metabolism and for whole-body<SUP> </SUP>glucose disposal in normal mice, a
finding that is consistent<SUP> </SUP>with a large body of additional experimental
data that has accumulated<SUP> </SUP>over the past several decades (for a review,
see Ref. <A HREF="#B4">4</A>).
</P>
<P>Surprisingly, however, muscles from the Glut1-overexpressing mice do
not exhibit further increases in glucose transport after<SUP> </SUP>treatments
that augment transport in normal muscles (insulin,<SUP> </SUP>hypoxia,
electrically induced contractions) (<A HREF="#B5">5</A>), despite the<SUP> </SUP>fact that Glut4
translocates to the sarcolemma and transverse<SUP> </SUP>tubules normally in the
transgenic muscles (<A HREF="#B6">6</A>). These data<SUP> </SUP>suggest that the intrinsic activity
of Glut4 can be subject to<SUP> </SUP>regulation in the plasma membrane domains of
muscle<SUP> </SUP>fibers.
</P>
<P>The dramatic elevation in basal glucose uptake in the muscles of
Glut1-overexpressing mice results in the near equilibration<SUP> </SUP>of free
glucose across the muscle fiber membranes, indicating<SUP> </SUP>that the
phosphorylation of glucose by hexokinase has become the<SUP> </SUP>rate-limiting
step in glucose uptake in these muscles (<A HREF="#B2">2</A>).<SUP> </SUP>This observation
demonstrates that hexokinase catalyzes a secondary<SUP> </SUP>rate-limiting step
in skeletal muscle glucose disposal that can<SUP> </SUP>become predominant if the
transport step is artificially elevated.<SUP> </SUP>It therefore seemed reasonable
that a further increase in muscle<SUP> </SUP>glucose uptake and whole-body glucose
disposal might be induced<SUP> </SUP>in Glut1-overexpressing mice by increasing
the expression of hexokinase<SUP> </SUP>in the muscles of these mice. This
hypothesis has an important<SUP> </SUP>practical implication for therapies
designed to counteract the<SUP> </SUP>insulin resistance and glucose intolerance
associated with type<SUP> </SUP>2&nbsp;diabetes (<A HREF="#B4">4</A>).
</P>
<P>In order to test this hypothesis, Glut1-overexpressing mice were mated
with mice that overexpress hexokinase II in skeletal<SUP> </SUP>muscle.
Surprisingly, the overexpression of hexokinase II in the<SUP> </SUP>muscles of
Glut1-overexpressing mice dramatically increased steady-state<SUP> </SUP>levels of
glucose 6-phosphate and glycogen, but did not augment<SUP> </SUP>whole-body
glucose disposal. Additionally, mice overexpressing<SUP> </SUP>hexokinase II alone
exhibited no increase in muscle glucose uptake<SUP> </SUP>or whole-body glucose
disposal compared with wild-type control<SUP> </SUP>mice. We conclude that
increasing hexokinase activity in muscle<SUP> </SUP>is not likely to be an
effective means of counteracting insulin<SUP> </SUP>resistance or glucose<SUP> </SUP>intolerance.
<BR><BR CLEAR=ALL>



<A NAME="SEC1"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;EXPERIMENTAL PROCEDURES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>EXPERIMENTAL PROCEDURES</FONT>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Materials--</I>

Purified porcine insulin (Iletin II) and human
insulin (Humulin R U-100) were purchased from Eli Lilly and Co.
Radioimmunoassay<SUP> </SUP>grade bovine serum albumin
(BSA</A>),<SUP>1</SUP> and the
nonradioactive forms of <font size=-1>D</font>-glucose,
2-deoxy-<font size=-1>D</font>-glucose<SUP> </SUP>(2-DG</A>), and <font size=-1>D</font>-mannitol were
obtained from Sigma. 2-Deoxy-<font size=-1>D</font>-
[1,2-<SUP>3</SUP>H]glucose, [5-<SUP>3</SUP>H]glucose, and
<SUP>3</SUP>H<SUB>2</SUB>O were purchased from American Radiolabeled
Chemicals. [U-<SUP>14</SUP>C]Mannitol and high pressure liquid
chromatography-purified 3-[<SUP>3</SUP>H]glucose were obtained from
NEN Life Science<SUP> </SUP>Products.



    

    


<P><I>Preparation of Transgenic Mice Overexpressing Glut1 and
Hexokinase II--</I>

Transgenic mice overexpressing human hexokinase II
in striated muscle (a kind gift from Drs. D.&nbsp;H.&nbsp;Wasserman and D.&nbsp;K.&nbsp;Granner)<SUP> </SUP>were constructed as described previously, using a transgene
containing<SUP> </SUP>the rat muscle creatinine kinase promoter-enhancer coupled
to<SUP> </SUP>the human hexokinase II cDNA and an 850-base pair cassette
(SVPA)<SUP> </SUP>containing the polyadenylation and splice site sequences of SV40<SUP> </SUP>(<A HREF="#B7">7</A>). The construction of transgenic mice overexpressing the<SUP> </SUP>human Glut1
glucose transporter was also described previously<SUP> </SUP>(<A HREF="#B1">1</A>). The minigene in
this construct contains a 2.47-kilobase<SUP> </SUP>cDNA fragment encoding the
human Glut1 glucose transporter under<SUP> </SUP>the regulation of the
1.2-kilobase rat myosin light chain-2 promoter.<SUP> </SUP>Expression of the
transgene is restricted to skeletal muscle and<SUP> </SUP>does not affect
expression of the Glut4 isoform. Male mice heterozygous<SUP> </SUP>for the Glut1
transgene were bred with female mice heterozygous<SUP> </SUP>for the hexokinase II
transgene to produce mice of four separate<SUP> </SUP>genotypes: those carrying
both transgenes, those carrying one<SUP> </SUP>of the two, and those carrying none
of the transgenes. The presence<SUP> </SUP>of the transgenes was determined by PCR
analysis of genomic DNA<SUP> </SUP>obtained from tail biopsy and prepared using
the QiAmp tissue<SUP> </SUP>isolation kit (Qiagen, Valencia, CA). Sex-matched
littermate mice<SUP> </SUP>between the ages of 2&nbsp;and 4&nbsp;months were used for all<SUP> </SUP>experiments.



    

    


<P><I>Animal Care and Tissue Preparation--</I>

Animals were housed in a
room maintained at 23&nbsp;&#176;C with a fixed 12-h light/dark cycle (lights
on 6&nbsp;a.m. to 6&nbsp;p.m.) and given<SUP> </SUP>free access to Purina chow and
water. On the morning of the experiment,<SUP> </SUP>animals were anesthetized with
pentobarbital sodium (5&nbsp;mg/100<SUP> </SUP>g body weight by intraperitoneal
injection). Extensor digitorum<SUP> </SUP>longus muscles were excised and
incubated for determination of<SUP> </SUP>2-DG</A> uptake or glucose<SUP> </SUP>utilization.



    

    


<P><I>Measurement of 2-Deoxyglucose Uptake--</I>

Extensor digitorum
longus muscles were incubated for 30&nbsp;min at 35&nbsp;&#176;C in 2&nbsp;ml of
oxygenated Krebs-Henseleit buffer (KHB</A>) supplemented<SUP> </SUP>with 8&nbsp;m<font size=-1>M</font> glucose, 32&nbsp;m<font size=-1>M</font> mannitol, and 0.1% BSA</A> in
the absence<SUP> </SUP>or presence of 2&nbsp;milliunits/ml porcine insulin. Next,
muscles<SUP> </SUP>were transferred to KHB</A> containing 40&nbsp;m<font size=-1>M</font> mannitol,
0.1% BSA</A>, and<SUP> </SUP>2&nbsp;milliunits/ml insulin for 10&nbsp;min to remove glucose
from the<SUP> </SUP>extracellular space prior to measurement of 2-DG</A> uptake as
described<SUP> </SUP>previously (<A HREF="#B8">8</A>). Briefly, muscles were incubated for 20&nbsp;min<SUP> </SUP>in
1.5&nbsp;ml of KHB</A> containing 1&nbsp;m<font size=-1>M</font>
2-deoxy-<font size=-1>D</font>-[1,2-<SUP>3</SUP>H]glucose (1.5&nbsp;&#181;Ci/mmol),
39&nbsp;m<font size=-1>M</font> [U-<SUP>14</SUP>C]mannitol (8.5&nbsp;&#181;Ci/mmol), and
0.1% BSA</A>. Insulin was added if<SUP> </SUP>it was present in previous incubations.
The gas phase was 95%<SUP> </SUP>O<SUB>2</SUB>, 5% CO<SUB>2</SUB>, and the
temperature was maintained at 29&nbsp;&#176;C. Muscle<SUP> </SUP>extracellular space and
intracellular 2-DG</A> concentration (&#181;mol&#183;ml<SUP> </SUP>intracellular
water<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">1</SUP>&#183;20 min<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">1</SUP>)
were determined as described previously (<A HREF="#B8">8</A>).



    

    


<P><I>Measurement of Muscle Glucose Metabolism Using
[<SUP>3</SUP>H]Glucose--</I>

<I>In vitro</I> rates of glucose
utilization via glycolysis and glucose incorporation into glycogen were
determined in skeletal muscle<SUP> </SUP>isolated from control and
hexokinase-overexpressing mice according<SUP> </SUP>to a modification (<A HREF="#B8">8</A>) of
previously described methods (<A HREF="#B9">9</A>,<SUP> </SUP><A HREF="#B10">10</A>). Extensor digitorum longus muscles
were incubated for 3<SUP>&nbsp;</SUP>h at 35&nbsp;&#176;C in 1&nbsp;ml of oxygenated KHB</A>
containing 2.25&nbsp;&#181;Ci of [5-<SUP>3</SUP>H]glucose under one of two
conditions: either 8&nbsp;m<font size=-1>M</font> glucose and<SUP> </SUP>20&nbsp;microunits/ml
porcine insulin or 24&nbsp;m<font size=-1>M</font> glucose and 2&nbsp;milliunits/ml<SUP> </SUP>insulin. Mannitol was added to the medium at a concentration sufficient<SUP> </SUP>to bring the total osmolality of glucose plus mannitol to 40&nbsp;milliosmolal.<SUP> </SUP>Using this technique, it has been demonstrated previously
that<SUP> </SUP>in isolated skeletal muscle, the sum of glucose utilization via<SUP> </SUP>glycolysis (measured as [<SUP>3</SUP>H]water formation from
[5-<SUP>3</SUP>H]glucose) plus the amount of tritium retained in
glycogen accounts<SUP> </SUP>for nearly all of the [5-<SUP>3</SUP>H]glucose
transported into the cell (<A HREF="#B11">11</A>).



    

    


<P><I>Measurement of Whole-body Glucose Disposal:
Euglycemic-Hyperinsulinemic Clamps--</I>

Clamp experiments were carried
out as described previously (<A HREF="#B3">3</A>, <A HREF="#B12">12</A>) with the following modifications.
After placement<SUP> </SUP>of the infusion catheter, an infusion of
3-[<SUP>3</SUP>H]glucose at 0.04&nbsp;&#181;Ci/min was begun for measurement
of the rate<SUP> </SUP>of appearance of glucose, hepatic glucose production, and
total<SUP> </SUP>body glucose utilization. The infusion was continued during a<SUP> </SUP>75-min control period, and 20&nbsp;&#181;l of blood was taken from the tail<SUP> </SUP>for
determination of glucose specific activity at 60,&nbsp;67.5&nbsp;and<SUP> </SUP>75&nbsp;min.
After 75&nbsp;min, an infusion of insulin (regular human) was<SUP> </SUP>begun at a
rate of 80&nbsp;milliunits/kg/min and continued for at least<SUP> </SUP>90&nbsp;min. An
infusion of dextrose (25%) was begun, and the infusion<SUP> </SUP>rate varied
during the clamp period to maintain the blood glucose<SUP> </SUP>at approximately
160&nbsp;mg/dl.
<P>
In all the clamps, the continuous infusion of
3-[<SUP>3</SUP>H]glucose tracer was continued during the insulin
infusion periods and, in<SUP> </SUP>addition, the tracer was added to the 25%
dextrose infusion to<SUP> </SUP>approximate the glucose specific activity in the
blood at the<SUP> </SUP>end of the control period. This approximation was based
upon measurement<SUP> </SUP>of specific activity during identical conditions in
the same type<SUP> </SUP>of mice in previous experiments. Blood samples for
determination<SUP> </SUP>of specific activity were taken 20&nbsp;and 10&nbsp;min prior to
and at<SUP> </SUP>the end of the experimental period. The glucose infusion rate<SUP> </SUP>was not changed for at least 20&nbsp;min prior to the first determination<SUP> </SUP>of
specific activity. Both the blood glucose and the glucose specific<SUP> </SUP>activity were in steady state during the control period and the<SUP> </SUP>clamp
sampling periods. Blood for insulin measurement was obtained<SUP> </SUP>by cardiac
puncture at the conclusion of the<SUP> </SUP>experiment.
<P>
Blood glucose was measured using 5&nbsp;&#181;l of whole blood in the Hemocue
blood glucose meter (Hemocue, Mission Viejo, CA). Plasma<SUP> </SUP>insulin was
measured by double-antibody radioimmunoassay using<SUP> </SUP>rat insulin
standards (Eli Lilly). Specific activity of glucose<SUP> </SUP>in whole blood was
determined by aqueous scintillation counting<SUP> </SUP>of 20&nbsp;&#181;l of blood
deproteinized with barium hydroxide (0.3&nbsp;<font size=-1>N</font>)<SUP> </SUP>and zinc
sulfate (0.3&nbsp;<font size=-1>N</font>). Aliquots of the resulting supernatant<SUP> </SUP>were
dried at 70&nbsp;&#176;C to remove tritiated water prior to resuspension<SUP> </SUP>and
liquid scintillation counting. The rate of appearance of glucose<SUP> </SUP>(<I>R</I><SUB>a</SUB>), which equals the rate of total body
glucose utilization<SUP> </SUP>(<I>R</I><SUB>d</SUB>) when the blood glucose
is in steady state, was calculated<SUP> </SUP>by dividing the infusion rate of
3-[<SUP>3</SUP>H]glucose by the specific activity at the same time.
Hepatic glucose<SUP> </SUP>production was calculated by subtracting the cold
glucose infusion<SUP> </SUP>rate from <I>R</I><SUB>a</SUB>.



    

    


<P><I>Measurement of Hexokinase Activity and Glut1 Glucose Transporter
Content--</I>

Total hexokinase activity and heat-stable hexokinase I
activity in quadriceps muscle homogenates (<A HREF="#B7">7</A>) were measured
enzymatically<SUP> </SUP>(<A HREF="#B13">13</A>). Hexokinase II activity was subsequently calculated
by<SUP> </SUP>subtracting hexokinase I from total hexokinase activity. Glucose<SUP> </SUP>transporter protein levels were determined in muscle homogenates<SUP> </SUP>by
immunoblotting, using rabbit polyclonal antibodies directed<SUP> </SUP>against the
C terminus of either Glut4 (Phe<SUP>349</SUP>) or Glut1
(Phe<SUP>350</SUP>) followed by horseradish peroxidase-conjugated
donkey anti-rabbit<SUP> </SUP>IgG. Antibody-bound proteins were detected using<SUP> </SUP>ECL.



    

    


<P><I>Measurement of Muscle Metabolites--</I>

Measurements of glycogen
and glucose 6-phosphate were performed using gastrocnemius muscles
clamp frozen <I>in situ</I>. Frozen muscles<SUP> </SUP>were homogenized in
ice-cold 0.3&nbsp;<font size=-1>M</font> perchloric acid; one aliquot<SUP> </SUP>of this
homogenate was analyzed for glycogen (<A HREF="#B14">14</A>), while the<SUP> </SUP>remaining
homogenate was centrifuged, and the resulting supernatant<SUP> </SUP>neutralized
with buffer containing 0.4&nbsp;<font size=-1>M</font> KCl, 2&nbsp;<font size=-1>N</font> KOH, and
0.4<SUP>&nbsp;</SUP><font size=-1>M</font> imidazole. Glucose and glucose 6-phosphate in this
fraction<SUP> </SUP>were measured fluorometrically (<A HREF="#B15">15</A>).



    

    


<P><I>Measurement of Plasma Metabolites--</I>

Mice fed <I>ad
libitum</I> were bled (~0.3 ml) from the tail. Plasma insulin
concentrations were measured by double-antibody radioimmunoassays<SUP> </SUP>using
human standards (Linco Research, Inc.). Blood glucose levels<SUP> </SUP>were
measured using a Hemocue glucose<SUP> </SUP>analyzer.



    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC2"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;RESULTS</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>RESULTS</FONT>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Overexpression of Hexokinase--</I>

Muscles were resected from
littermate mice expressing the Glut1 transgene, the hexokinase II
transgene, both transgenes, or<SUP> </SUP>control non-transgenic littermates and
analyzed for the expression<SUP> </SUP>of hexokinase I, hexokinase II, and total
hexokinase activities.<SUP> </SUP>Fig. <a href="#F1">1</a> shows that
the two groups of mice expressing the hexokinase<SUP> </SUP>II transgene exhibited
similar (7.1-&nbsp;and 8.2-fold, respectively)<SUP> </SUP>increases in total hexokinase
activity, due mostly to a specific<SUP> </SUP>increase in hexokinase II activity.
The small increase in hexokinase<SUP> </SUP>I activity observed in these two
groups is probably due to the<SUP> </SUP>fact that the assays do not
quantitatively distinguish between<SUP> </SUP>the two isoforms. Glut1 transgenic
mice exhibited a small increase<SUP> </SUP>in total hexokinase activity in muscle
compared with their wild-type<SUP> </SUP>siblings. These data are consistent with
previously published<SUP> </SUP>data concerning Glut1 (<A HREF="#B2">2</A>) and hexokinase II
(<A HREF="#B7">7</A>)-overexpressing<SUP> </SUP>transgenic mice.



<BR CLEAR=ALL><A NAME="F1"><!-- FIG 1 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/29/22381/F1">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=132 SRC="/content/vol275/issue29/images/small/bc2406599001.gif"></A><BR>

<STRONG>View larger version</STRONG> (27K):
<BR><NOBR><A HREF="/cgi/content/full/275/29/22381/F1">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/29/22381/F1"
onClick="startTarget('F1', 590, 491); this.href='/cgi/content-nw/full/275/29/22381/F1'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F1">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 1. &nbsp;</STRONG>

<B>Hexokinase activity in quadriceps muscles
from control and transgenic mice.</B> Total, type I, and type II
hexokinase activities were determined on muscle homogenates from
wild-type mice or mice overexpressing Glut1 (<I>Glut1</I>),
hexokinase II (<I>Hex</I>), or both transgenes (<I>Glut1&nbsp;&#215;&nbsp;Hex</I>) as described under "Experimental Procedures." The values
represent the mean&nbsp;&#177;&nbsp;S.E. for 4-6 individual muscles per group.
*, <I>p</I>&nbsp;&lt;&nbsp;0.001&nbsp;for Hex or Glut1&nbsp;&#215;&nbsp;Hex
<I>versus</I> wild-type or Glut1.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 1 -->







    

    


<P><I>Characterization of Mice Overexpressing Hexokinase Alone--</I>

In
order to determine whether overexpression of hexokinase II induced an
alteration in glucose transport activity, 2-deoxyglucose<SUP> </SUP>uptake
measurements were performed on isolated extensor digitorum<SUP> </SUP>longus
muscles. Fig. <a href="#F2">2</a> shows that neither basal
nor insulin-stimulated<SUP> </SUP>glucose transport was significantly altered in
hexokinase II-overexpressing<SUP> </SUP>muscles. Similar results were observed in
isolated soleus muscles<SUP> </SUP>(data not shown). These results suggest that
overexpression of<SUP> </SUP>hexokinase II in muscle did not directly or
indirectly impact<SUP> </SUP>on glucose transporter expression, regulation, or
activity. Immunoblot<SUP> </SUP>analysis confirmed that neither Glut1 nor Glut4
protein levels<SUP> </SUP>were altered in the skeletal muscle of hexokinase
overexpressing<SUP> </SUP>mice relative to wild-type littermates, nor were Glut1
or Glut4<SUP> </SUP>protein levels altered in Glut1&nbsp;&#215;&nbsp;Hex mice relative to
Glut1 mice<SUP> </SUP>(data not shown).



<BR CLEAR=ALL><A NAME="F2"><!-- FIG 2 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/29/22381/F2">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=124 SRC="/content/vol275/issue29/images/small/bc2406599002.gif"></A><BR>

<STRONG>View larger version</STRONG> (33K):
<BR><NOBR><A HREF="/cgi/content/full/275/29/22381/F2">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/29/22381/F2"
onClick="startTarget('F2', 590, 473); this.href='/cgi/content-nw/full/275/29/22381/F2'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F2">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 2. &nbsp;</STRONG>

<B>Glucose transport activity of muscles from
wild-type and transgenic mice.</B> Extensor digitorum longus muscles
were excised from wild-type mice or mice overexpressing Glut1
(<I>Glut1</I>), hexokinase II (<I>Hex</I>), or both transgenes
(<I>Glut1</I>&nbsp;&#215;&nbsp;<I>Hex</I>). Muscles were subjected to
[<SUP>3</SUP>H]2-deoxyglucose uptake assays as described under
"Experimental Procedures." The values represent the mean&nbsp;&#177;&nbsp;S.E. for 8-10 individual muscles per group. *, <I>p</I>&nbsp;&lt;&nbsp;0.001&nbsp;for Glut1 or Glut1&nbsp;&#215;&nbsp;Hex <I>versus</I> wild-type or
Hex.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 2 -->




<P>
In order to determine whether hexokinase overexpression by itself can
augment muscle glucose metabolite levels, steady-state<SUP> </SUP>glucose
6-phosphate and glycogen levels were measured in muscles<SUP> </SUP>clamp frozen
<I>in situ</I> from the four groups of mice. Fig.
<a href="#F3">3</a> shows<SUP> </SUP>that neither metabolite was
altered in the muscles of mice overexpressing<SUP> </SUP>hexokinase II compared
with wild-type littermates. This is consistent<SUP> </SUP>with the observation
that transport, not phosphorylation, is rate-limiting<SUP> </SUP>for glucose
metabolism in normal mouse muscle.



<BR CLEAR=ALL><A NAME="F3"><!-- FIG 3 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/29/22381/F3">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=134 HEIGHT=200 SRC="/content/vol275/issue29/images/small/bc2406599003.gif"></A><BR>

<STRONG>View larger version</STRONG> (14K):
<BR><NOBR><A HREF="/cgi/content/full/275/29/22381/F3">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/29/22381/F3"
onClick="startTarget('F3', 444, 640); this.href='/cgi/content-nw/full/275/29/22381/F3'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F3">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 3. &nbsp;</STRONG>

<B>Steady-state metabolite levels in muscles
from wild-type and transgenic mice.</B> Gastrocnemius muscles from
wild-type mice or mice overexpressing Glut1 (<I>Glut1</I>),
hexokinase II (<I>Hex</I>), or both transgenes
(<I>Glut1</I>&nbsp;&#215;&nbsp;<I>Hex</I>) were clamp frozen <I>in
situ</I>, resected, homogenized, and then used to measure steady-state
concentrations of glucose 6-phosphate (<I>A</I>) and glycogen
(<I>B</I>) as described under "Experimental Procedures." The
values given represent the mean&nbsp;&#177;&nbsp;S.E. for 8-10 individual
muscles per group. *, <I>p</I>&nbsp;&lt;&nbsp;0.001&nbsp;for Glut1&nbsp;&#215;&nbsp;Hex
<I>versus</I> all other groups; **, <I>p</I>&nbsp;&lt;&nbsp;0.01&nbsp;for
Glut1 <I>versus</I> wild-type or Hex.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 3 -->




<P>
A previous study with hexokinase-overexpressing mice suggested that
hexokinase may become rate-limiting or partially rate-limiting<SUP> </SUP>for
glucose metabolism in skeletal muscle under conditions of<SUP> </SUP>hyperinsulinemia and/or hyperglycemia (<A HREF="#B7">7</A>), but direct evidence<SUP> </SUP>in the
form of glucose tracer analysis in isolated muscles was<SUP> </SUP>not provided.
In order to address this issue, the metabolism of<SUP> </SUP>[5-<SUP>3</SUP>H]glucose was examined in muscles isolated from
control and hexokinase<SUP> </SUP>II-overexpressing mice. Fig.
<a href="#F4">4</a> shows that under both basal (8<SUP>&nbsp;</SUP>m<font size=-1>M</font> glucose, 20&nbsp;microunits/ml insulin) and
hyperglycemic/hyperinsulinemic<SUP> </SUP>(24&nbsp;m<font size=-1>M</font> glucose, 2&nbsp;milliunits/ml insulin) conditions, neither glycolytic<SUP> </SUP>nor glycogenic
utilization of glucose was increased in muscles<SUP> </SUP>from hexokinase II
transgenic mice compared with wild-type littermates.<SUP> </SUP>These data are in
complete agreement with the data presented above<SUP> </SUP>on steady-state levels
of glucose metabolites and further confirm<SUP> </SUP>the rate-limiting nature of
the transport step in normal muscle.<SUP> </SUP>


<BR CLEAR=ALL><A NAME="F4"><!-- FIG 4 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/29/22381/F4">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=111 HEIGHT=200 SRC="/content/vol275/issue29/images/small/bc2406599004.gif"></A><BR>

<STRONG>View larger version</STRONG> (38K):
<BR><NOBR><A HREF="/cgi/content/full/275/29/22381/F4">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/29/22381/F4"
onClick="startTarget('F4', 394, 640); this.href='/cgi/content-nw/full/275/29/22381/F4'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F4">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 4. &nbsp;</STRONG>

<B>Rates of glycolytic and glycogenic glucose
utilization in muscles from control and hexokinase transgenic
mice.</B> Extensor digitorum longus muscles from wild-type and
hexokinase (<I>Hex</I>) transgenic mice were resected, incubated in
the presence of [5-<SUP>3</SUP>H] glucose and either 8&nbsp;m<font size=-1>M</font> cold glucose, 20&nbsp;microunits/ml insulin (<I>Low
Gluc/Ins</I>) or 24&nbsp;m<font size=-1>M</font> cold glucose, 2&nbsp;milliunits/ml
insulin (<I>High Gluc/Ins</I>). The amounts of the isotope
incorporated into H<SUB>2</SUB>O (<I>A</I>) or glycogen
(<I>B</I>) were then determined as described under "Experimental
Procedures." Values represent the mean&nbsp;&#177;&nbsp;S.E. for 6-8
individual muscles per group.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 4 -->




<P>
In order to determine the effect of the hexokinase transgene on
whole-body glucose homeostasis, blood glucose and whole-body<SUP> </SUP>glucose
disposal measurements were conducted. Fig.
<a href="#F5">5</a> shows that<SUP> </SUP>expression of the hexokinase
II transgene alone had no significant<SUP> </SUP>effect on fed blood glucose
levels compared with wild-type controls.<SUP> </SUP>Fig.
<a href="#F6">6</a> shows that the hexokinase transgene
alone had no significant<SUP> </SUP>effect on whole-body glucose disposal
(<I>R</I><SUB>d</SUB>) in either the basal<SUP> </SUP>state or during a
hyperinsulinemic/euglycemic clamp.



<BR CLEAR=ALL><A NAME="F5"><!-- FIG 5 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/29/22381/F5">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=129 SRC="/content/vol275/issue29/images/small/bc2406599005.gif"></A><BR>

<STRONG>View larger version</STRONG> (14K):
<BR><NOBR><A HREF="/cgi/content/full/275/29/22381/F5">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/29/22381/F5"
onClick="startTarget('F5', 590, 484); this.href='/cgi/content-nw/full/275/29/22381/F5'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F5">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 5. &nbsp;</STRONG>

<B>Blood glucose levels in control and
transgenic mice.</B> Blood was obtained from the tail veins of freely
feeding wild-type mice or mice expressing the hexokinase transgene
(<I>Hex</I>), the Glut1 transgene (<I>Glut1</I>) or both
transgenes (<I>Glut1&nbsp;&#215;&nbsp;Hex</I>). Glucose concentrations were
determined as described under "Experimental Procedures." Values
given represent mean&nbsp;&#177;&nbsp;S.E. for 11-22 animals per group. *,
<I>p</I>&nbsp;&lt;&nbsp;0.001&nbsp;for Glut1 or Glut1&nbsp;&#215;&nbsp;Hex
<I>versus</I> wild-type or Hex.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 5 -->







<BR CLEAR=ALL><A NAME="F6"><!-- FIG 6 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/29/22381/F6">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=122 SRC="/content/vol275/issue29/images/small/bc2406599006.gif"></A><BR>

<STRONG>View larger version</STRONG> (33K):
<BR><NOBR><A HREF="/cgi/content/full/275/29/22381/F6">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/29/22381/F6"
onClick="startTarget('F6', 590, 468); this.href='/cgi/content-nw/full/275/29/22381/F6'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F6">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 6. &nbsp;</STRONG>

<B>Rates of whole-body glucose disposal in
control and transgenic mice.</B> Wild-type mice or mice carrying the
hexokinase transgene (<I>Hex</I>), the Glut1 transgene
(<I>Glut1</I>), or both transgenes (<I>Glut1</I>&nbsp;&#215;&nbsp;<I>Hex</I>) were subjected to a euglycemic/hyperinsulinemic clamp
procedure along with the infusion of [<SUP>3</SUP>H]glucose to
ascertain the rate of whole-body glucose disposal under basal and
hyperinsulinemic conditions (see "Experimental Procedures"). Values
given represent the mean&nbsp;&#177;&nbsp;S.E. for 4&nbsp;animals per group. *,
<I>p</I>&nbsp;&lt;&nbsp;0.01&nbsp;for Glut1 or Glut1&nbsp;&#215;&nbsp;Hex
<I>versus</I> wild-type or Hex; **, <I>p</I>&nbsp;&lt;&nbsp;0.05&nbsp;for
Glut1 <I>versus</I> wild-type or Hex.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 6 -->







    

    


<P><I>Characterization of Mice Overexpressing Both Hexokinase and
Glut1--</I>

Steady-state Glucose-6-phosphate levels were increased
2.4-fold and glycogen was increased 5.4-fold in muscles from Glut1<SUP> </SUP>transgenic mice (Fig. <a href="#F3">3</a>). Increasing hexokinase activity in muscles<SUP> </SUP>that also overexpress Glut1 caused a further dramatic elevation<SUP> </SUP>in
glucose 6-phosphate (7.6-fold compared with wild-type and 3.2-fold<SUP> </SUP>compared with Glut1-overexpressing muscles) and glycogen (40.5-fold<SUP> </SUP>compared with wild-type and 7.5-fold compared with Glut1-overexpressing<SUP> </SUP>muscles). These observations are completely consistent with the<SUP> </SUP>observation that phosphorylation is rate-limiting for glucose<SUP> </SUP>uptake in
the muscles of the Glut1 transgenic mice (<A HREF="#B2">2</A>).
<P>
The massive overexpression of glycogen in muscles of the doubly
transgenic animals resulted in a dramatic disruption in the<SUP> </SUP>normal
ultrastructure of striated muscle (see Fig.
<a href="#F7">7</a>). Myofibrils<SUP> </SUP>in the doubly transgenic
mice exhibited greater electron density<SUP> </SUP>compared with mice
overexpressing hexokinase alone, which exhibited<SUP> </SUP>a normal muscle
architecture, and the myofibril bundles were disrupted<SUP> </SUP>by numerous
glycogen deposits, some of them very large in size.<SUP> </SUP>Despite their
grossly abnormal muscle architecture, the doubly<SUP> </SUP>transgenic mice did
not display any obvious change in mobility<SUP> </SUP>or behavior compared with
their non-transgenic siblings.



<BR CLEAR=ALL><A NAME="F7"><!-- FIG 7 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/29/22381/F7">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=170 SRC="/content/vol275/issue29/images/small/bc2406599007.gif"></A><BR>

<STRONG>View larger version</STRONG> (132K):
<BR><NOBR><A HREF="/cgi/content/full/275/29/22381/F7">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/29/22381/F7"
onClick="startTarget('F7', 590, 574); this.href='/cgi/content-nw/full/275/29/22381/F7'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F7">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 7. &nbsp;</STRONG>

<B>Ultrastructure of muscle from transgenic
mice.</B> Extensor digitorum longus muscles were resected from mice
overexpressing hexokinase (<I>Hex</I>) or both Glut1 and hexokinase
(<I>Glut1</I>&nbsp;&#215;&nbsp;<I>Hex</I>) and then processed for
electron microscopy as described previously (<A HREF="#B22">22</A>). Cross-sections
through the muscle fibers are shown. Muscles from Hex mice exhibit a
normal ultrastructure, whereas muscles from Glut1&nbsp;&#215;&nbsp;Hex mice
display an abnormal architecture due to the large increase in glycogen
content. Note the unusually high electron density of the myofibrils in
the Glut1&nbsp;&#215;&nbsp;Hex muscle and the large and small glycogen deposits
interrupting the bundles of myofibrils. <I>Mi</I>, mitochondria;
<I>F</I>, myofibrils; <I>G</I>, glycogen. The <I>small
arrows</I> point to small glycogen deposits within myofibril
bundles.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 7 -->




<P>
Consistent with previously published results (<A HREF="#B3">3</A>, <A HREF="#B12">12</A>),
Glut1-overexpressing mice exhibited increases in basal whole-body<SUP> </SUP>glucose disposal and insulin-stimulated whole-body glucose disposal<SUP> </SUP>under euglycemic/hyperinsulinemic clamp conditions compared with<SUP> </SUP>wild-type littermates (Fig. <a href="#F6">6</a>). Because overexpression of hexokinase<SUP> </SUP>in
the context of Glut1 overexpression dramatically increased<SUP> </SUP>steady-state
levels of muscle metabolites compared with overexpression<SUP> </SUP>of Glut1
alone (see Fig. <a href="#F3">3</a>), it was expected that whole-body glucose<SUP> </SUP>disposal
would be markedly elevated in the Glut1&nbsp;&#215;&nbsp;Hex mice relative<SUP> </SUP>to
the Glut1 mice. Surprisingly, however, no significant difference<SUP> </SUP>was
observed in basal or insulin-stimulated whole-body glucose<SUP> </SUP>disposal in
Glut1&nbsp;&#215;&nbsp;Hex mice compared with Glut1<SUP> </SUP>mice.



    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC3"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;DISCUSSION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>DISCUSSION</FONT>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    
    <P>The data presented in this study are consistent with a large body
of previous experimental data indicating that, under most<SUP> </SUP>conditions
and in most skeletal muscle types, transport of glucose<SUP> </SUP>is
rate-limiting for glucose uptake and metabolism (<A HREF="#B4">4</A>). However,<SUP> </SUP>it is
possible that in some skeletal muscle types, <I>i.e.</I> those<SUP> </SUP>expressing a relatively high Glut4/hexokinase II ratio, the
phosphorylation<SUP> </SUP>step may become partially rate-limiting for overall
glucose metabolism<SUP> </SUP>under certain conditions (<A HREF="#B16">16</A>).
    
    </P>

    
    <P>One unanticipated finding of this study is that the hexokinase
transgene did not further augment whole-body glucose disposal<SUP> </SUP>in mice
that also overexpress Glut1 in muscle. The observation<SUP> </SUP>that
intracellular free glucose is dramatically elevated in the<SUP> </SUP>muscle of
Glut1 transgenic mice (<A HREF="#B2">2</A>) indicates that the hexokinase<SUP> </SUP>step is
rate-limiting for glucose metabolism in Glut1-overexpressing<SUP> </SUP>muscles.
Consistent with this interpretation is the finding that<SUP> </SUP>the muscles of
doubly transgenic mice exhibited elevated steady-state<SUP> </SUP>glucose
6-phosphate and glycogen levels relative to muscles overexpressing<SUP> </SUP>Glut1 alone (Fig. <a href="#F3">3</a>), implying an increased flux through the glycogenic<SUP> </SUP>pathway mediated by the hexokinase transgene. Why then are the<SUP> </SUP>elevated
steady-state metabolite levels in doubly transgenic muscles<SUP> </SUP>not
associated with a further increase in whole-body glucose disposal<SUP> </SUP>relative to mice that only carry the Glut1 transgene? There are<SUP> </SUP>several
possible explanations, one being that the grossly elevated<SUP> </SUP>steady-state
glycogen level caused an inhibition of <I>de novo</I> glycogen<SUP> </SUP>synthesis in muscles of the doubly transgenic mice (<A HREF="#B17">17</A>). Support<SUP> </SUP>for
this interpretation is provided by the observation that muscles<SUP> </SUP>of
Glut1 transgenic mice with a 5-fold elevation in steady-state<SUP> </SUP>glycogen
levels relative to control muscles exhibit a 50% reduction<SUP> </SUP>in the
proportion of glycogen synthase in the active form (<A HREF="#B2">2</A>).<SUP> </SUP>Inhibition of
flux through the glycogenic pathway due to the very<SUP> </SUP>high glycogen
levels probably contributed to the grossly elevated<SUP> </SUP>glucose 6-phosphate
levels in the muscles of mice carrying both<SUP> </SUP>transgenes. Because
glycogen synthesis is the major pathway for<SUP> </SUP>the disposal of glucose in
muscle under hyperinsulinemic conditions<SUP> </SUP>(<A HREF="#B18">18</A>), this could explain why
the doubly transgenic mice do not<SUP> </SUP>exhibit a further increase in
whole-body glucose disposal during<SUP> </SUP>the euglycemic/hyperinsulinemic
clamp<SUP> </SUP>procedure.
    
    </P>

    
    <P>Our data are in apparent disagreement with data published previously on
hexokinase II transgenic mice. Chang and colleagues<SUP> </SUP>(<A HREF="#B7">7</A>) reported that
hexokinase II-overexpressing extensor digitorum<SUP> </SUP>longus and soleus
muscles exhibited increased 2-deoxyglucose uptake<SUP> </SUP>relative to control
muscles, especially in the presence of pharmacologic<SUP> </SUP>concentrations of
insulin. We observed no increase in 2-deoxyglucose<SUP> </SUP>uptake in either
muscle type in the presence or absence of insulin<SUP> </SUP>(Fig. <a href="#F2">2</a>). The data of
Chang and colleagues (<A HREF="#B7">7</A>) imply that hexokinase<SUP> </SUP>overexpression augmented
the activity and/or expression of endogenous<SUP> </SUP>glucose transporters in
skeletal muscle, because 2-deoxyglucose<SUP> </SUP>uptake reflects transport
activity and not hexokinase activity<SUP> </SUP>under the conditions employed in
these experiments (<A HREF="#B19">19</A>). This<SUP> </SUP>is also definitively demonstrated by our
uptake data where severalfold<SUP> </SUP>increases in hexokinase activity had no
effect on the rate of<SUP> </SUP>2-deoxyglucose uptake (see Fig. <a href="#F2">2</a>). However,
since hexokinase<SUP> </SUP>activity appears to be rate-limiting for glucose
uptake in the<SUP> </SUP>muscles of Glut1-overexpressing mice, one might expect to
observe<SUP> </SUP>an increase in 2-deoxyglucose uptake after transgenic
augmentation<SUP> </SUP>of hexokinase activity in these muscles. The explanation
for the<SUP> </SUP>inability of hexokinase to increase 2-deoxyglucose uptake in
Glut1-overexpressing<SUP> </SUP>mice lies in the lack of feedback inhibition of
hexokinase activity<SUP> </SUP>by 2-deoxyglucose-6-P. Even at a concentration of
30&nbsp;m<font size=-1>M</font>, 2-deoxyglucose-6-P<SUP> </SUP>fails to inhibit hexokinase
activity in muscle homogenates, whereas<SUP> </SUP>glucose-6-P inhibits hexokinase
activity by 80% at a concentration<SUP> </SUP>of 500&nbsp;&#181;<font size=-1>M</font> (<A HREF="#B19">19</A>). Thus,
<I>in situ</I>, with an ambient blood glucose<SUP> </SUP>concentration of ~8
m<font size=-1>M</font> and an intracellular glucose-6-P concentration<SUP> </SUP>of ~0.8
m<font size=-1>M</font> (see Fig. <a href="#F3">3</a>), hexokinase activity was severely inhibited<SUP> </SUP>and was rate-limiting for glucose uptake in the muscles of
Glut1-overexpressing<SUP> </SUP>mice. However, when muscles were removed and then
incubated under<SUP> </SUP>conditions used to measure 2-deoxyglucose uptake (no
glucose and<SUP> </SUP>1&nbsp;m<font size=-1>M</font> 2-deoxyglucose), the lack of feedback
inhibition restored<SUP> </SUP>hexokinase activity to the point where transport
once again became<SUP> </SUP>rate-limiting for uptake. Thus, 2-deoxyglucose uptake
in isolated<SUP> </SUP>tissues continues to reflect only the rate of glucose
transport<SUP> </SUP>in the muscles of Glut1-overexpressing mice, even though
hexokinase<SUP> </SUP>is rate-limiting for glucose uptake in muscle <I>in
situ</I>.
    
    </P>

    
    <P>If indeed the hexokinase-overexpressing mice studied by Chang and
colleagues (<A HREF="#B7">7</A>) also exhibited an increase in the activity<SUP> </SUP>of an
endogenous glucose transporter, then that would explain<SUP> </SUP>other
differences between their data and ours. For example, Chang<SUP> </SUP>and
colleagues (<A HREF="#B7">7</A>) reported a small but significant increase<SUP> </SUP>in glucose
6-phosphate levels in gastrocnemius muscles isolated<SUP> </SUP>from hexokinase
transgenic mice after a bolus injection of glucose<SUP> </SUP>and insulin, but we
observed no such increase under steady-state<SUP> </SUP>conditions. The increase
they observed may in fact have been due<SUP> </SUP>to an increase in glucose
transport activity in their mice. In<SUP> </SUP>a different collaborative study
(<A HREF="#B20">20</A>), some of the same investigators<SUP> </SUP>reported that
hexokinase-overexpressing mice exhibited increases<SUP> </SUP>in the glucose
utilization index of gluteal and gastrocnemius<SUP> </SUP>muscles under
hyperglycemic/hyperinsulinemic clamp conditions.<SUP> </SUP>It is possible that
this was also due to an increase in the activity<SUP> </SUP>of an endogenous
glucose transporter isoform expressed in the<SUP> </SUP>skeletal muscles of the
hexokinase transgenic mice. In support<SUP> </SUP>of this suggestion, mice that
overexpressed both Glut4 and hexokinase<SUP> </SUP>II had lower rates of muscle
glucose utilization than mice overexpressing<SUP> </SUP>the Glut4 transgene alone
(<A HREF="#B20">20</A>), and these differences in the<SUP> </SUP><I>in situ</I> glucose
utilization rates paralleled the differences in<SUP> </SUP>muscle 2-deoxglucose
uptake data, <I>i.e.</I> muscles overexpressing<SUP> </SUP>both hexokinase and
Glut4 exhibited lower rates of 2-deoxyglucose<SUP> </SUP>uptake in the presence of
insulin than muscles overexpressing<SUP> </SUP>Glut4 alone. Why mice that
overexpress both Glut4 and hexokinase<SUP> </SUP>might have lower glucose uptake
rates than mice that overexpress<SUP> </SUP>hexokinase alone remains unclear, but
this observation is consistent<SUP> </SUP>with a dominant role for transport as
compared with phosphorylation<SUP> </SUP>in determining the rate of muscle glucose
disposal, and supports<SUP> </SUP>the hypothesis that increases in metabolism
observed in the hexokinase-overexpressing<SUP> </SUP>muscles may in fact have been
due to an increase in endogenous<SUP> </SUP>glucose transport activity rather than
the increase in hexokinase<SUP> </SUP>activity.
    
    </P>

    
    <P>The hexokinase transgenic mice used in our study were derived from the
line originally constructed by Chang and colleagues<SUP> </SUP>(<A HREF="#B7">7</A>). One difference
is that we cross-bred the original hexokinase<SUP> </SUP>line (in a FVB/NJ
background) with a different hybrid strain of<SUP> </SUP>mice that overexpress
Glut1 (C57BL/6&nbsp;&#215;&nbsp;SJL), so that all four<SUP> </SUP>mouse genotypes studied
were in a FVB/NJ&nbsp;&#215;&nbsp;(C57BL/6&nbsp;&#215;&nbsp;SJL) background.<SUP> </SUP>This may
account for some of the differences observed by Chang<SUP> </SUP>and colleagues
(<A HREF="#B7">7</A>) and by us. Regardless, our data on hexokinase-overexpressing<SUP> </SUP>mice
as well as the data described previously by others, when<SUP> </SUP>analyzed in
the present context, are consistent with a dominant<SUP> </SUP>if not exclusive
role for glucose transport in determining the<SUP> </SUP>rate of muscle glucose
metabolism and whole-body glucose disposal<SUP> </SUP>in mice. This conclusion is
in agreement with a recent elegant<SUP> </SUP>study employing NMR that directly
measured the concentration of<SUP> </SUP>free glucose and glucose 6-phosphate in
human skeletal muscle<SUP> </SUP>(<A HREF="#B21">21</A>). This study demonstrated that glucose
transport, as opposed<SUP> </SUP>to phosphorylation, is rate-limiting for muscle
glucose disposal<SUP> </SUP>under hyperglycemic/hyperinsulinemic conditions in
normal subjects<SUP> </SUP>and in type 2<SUP>&nbsp;</SUP>diabetics.
    
    


<BR><BR CLEAR=ALL>

</TXT>



<!-- Stray figures and tables -->


<!-- Acknowledgements -->

<!-- Notes -->


<!-- Footnotes -->

<A NAME="foo"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;FOOTNOTES</FONT></TH>
</TR>
</TABLE>



<P><A NAME="FN150"><SUP>*</SUP></A>
This work was supported in part by National Institutes of
Health Grants DK38495 (to M.&nbsp;M.) and DK18986 (to J.&nbsp;O.&nbsp;H.) and by<SUP> </SUP>the Diabetes Research and Training Center at Washington
University<SUP> </SUP>School of Medicine.The costs of publication of this
article were<SUP> </SUP>defrayed in part by the
payment of page charges. The article
must<SUP> </SUP>therefore be hereby marked
"<I>advertisement</I>" in
accordance with<SUP> </SUP>18&nbsp;U.S.C. Section
1734&nbsp;solely to indicate this<SUP> </SUP>fact.

<P>
<P><A NAME="FN153"><SUP>&#167;</SUP></A>
These authors contributed equally to this<SUP> </SUP>work.

<P>
<P><A NAME="FN160"><SUP>**</SUP></A>
To whom correspondence should be addressed: Dept. of Cell Biology
and Physiology, Washington University School of Medicine,<SUP> </SUP>Box 8228,&nbsp;660&nbsp;S.&nbsp;Euclid Ave., St. Louis, MO 63110.&nbsp;E-mail: mike@<SUP> </SUP>cellbio.wustl.edu.

<P>


<P>
Published, JBC Papers in Press, April 11,&nbsp;2000,&nbsp;DOI 10.1074/jbc.M001946200

<P>

<A NAME="abb"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABBREVIATIONS</FONT></TH>
</TR>
</TABLE>

<P>The abbreviations used are: 

BSA, bovine serum
albumin;

2-DG, 2-deoxyglucose;

KHB, Krebs-Henseleit buffer.

</P>


<!-- Appendices -->

<!-- Bibliography -->




<A NAME="References"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;REFERENCES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">DISCUSSION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>REFERENCES</FONT>
</FONT></TH>
</TR></TABLE>

<BR CLEAR=ALL>
<TABLE BORDER=0>
<TR><TD VALIGN=TOP><a name="B1">1.</a>
    <TD VALIGN=TOP>

Marshall, B. A.,
Ren, J. M.,
Johnson, D. W.,
Gibbs, E. M.,
Lillquist, J. S.,
Soeller, W. C.,
Holloszy, J. O.,
 and Mueckler, M.



(1993)

<I>J. Biol. Chem.</I>
<B>268</B>,
18442-18445<!-- HIGHWIRE ID="275:29:22381:1" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=268/25/18442"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B2">2.</a>
    <TD VALIGN=TOP>

Ren, J. M.,
Marshall, B. A.,
Gulve, E. A.,
Gao, J.,
Johnson, D. W.,
Holloszy, J. O.,
 and Mueckler, M.



(1993)

<I>J. Biol. Chem.</I>
<B>268</B>,
16113-16115<!-- HIGHWIRE ID="275:29:22381:2" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=268/22/16113"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B3">3.</a>
    <TD VALIGN=TOP>

Marshall, B. A.,
Hansen, P. A.,
Ensor, N. J.,
Ogden, M. A.,
 and Mueckler, M.



(1999)

<I>Am. J.&nbsp;Physiol.</I>
<B>276</B>,
E390-E400<!-- HIGHWIRE ID="275:29:22381:3" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=276/2/E390"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B4">4.</a>
    <TD VALIGN=TOP>

Mueckler, M.



(1995)

<I>News Physiol. Sci.</I>
<B>10</B>,
22-29<!-- HIGHWIRE ID="275:29:22381:4" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=nips&resid=10/1/22">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B5">5.</a>
    <TD VALIGN=TOP>

Gulve, E. A.,
Ren, J. M.,
Marshall, B. A.,
Gao, J.,
Hansen, P. A.,
Holloszy, J. O.,
 and Mueckler, M.



(1994)

<I>J. Biol. Chem.</I>
<B>269</B>,
18366-18370<!-- HIGHWIRE ID="275:29:22381:5" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=269/28/18366"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B6">6.</a>
    <TD VALIGN=TOP>

Hansen, P. A.,
Wang, W.,
Marshall, B. A.,
Holloszy, J. O.,
 and Mueckler, M.



(1998)

<I>J. Biol. Chem.</I>
<B>273</B>,
18173-18179<!-- HIGHWIRE ID="275:29:22381:6" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=273/29/18173"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B7">7.</a>
    <TD VALIGN=TOP>

Chang, P. Y.,
Jensen, J.,
Printz, R. L.,
Granner, D. K.,
Ivy, J. L.,
 and Moller, D. E.



(1996)

<I>J. Biol. Chem.</I>
<B>271</B>,
14834-14839<!-- HIGHWIRE ID="275:29:22381:7" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=271/25/14834"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B8">8.</a>
    <TD VALIGN=TOP>

Hansen, P. A.,
Gulve, E. A.,
Marshall, B. A.,
Gao, J.,
Pessin, J. E.,
Holloszy, J. O.,
 and Mueckler, M.



(1995)

<I>J. Biol. Chem.</I>
<B>270</B>,
1679-1684<!-- HIGHWIRE ID="275:29:22381:8" --><A HREF="/cgi/ijlink?linkType=PDF&journalCode=jbc&resid=270/5/1679"><nobr>[<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B9">9.</a>
    <TD VALIGN=TOP>

Stauffacher, W.,
 and Renold, A. E.



(1969)

<I>Am. J.&nbsp;Physiol.</I>
<B>216</B>,
98-105<!-- HIGHWIRE ID="275:29:22381:9" --><A HREF="/cgi/external_ref?access_num=5765597&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=5765597&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B10">10.</a>
    <TD VALIGN=TOP>

Zawalich, W. S.,
 and Matchinsky, F. M.



(1977)

<I>Endocrinology</I>
<B>100</B>,
1-8<!-- HIGHWIRE ID="275:29:22381:10" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=endo&resid=100/1/1">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B11">11.</a>
    <TD VALIGN=TOP>

Nesher, R.,
Karl, I. E.,
 and Kipnis, D. M.



(1985)

<I>Am. J.&nbsp;Physiol.</I>
<B>249</B>,
C226-C232<!-- HIGHWIRE ID="275:29:22381:11" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpcell&resid=249/3/C226">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B12">12.</a>
    <TD VALIGN=TOP>Marshall, B.&nbsp;A., and Mueckler, M.&nbsp;M.&nbsp;(1994) <I>Am. J.&nbsp;Physiol.</I> E738-E744
    <!-- HIGHWIRE ID="275:29:22381:12" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B13">13.</a>
    <TD VALIGN=TOP>

Crane, R. K.,
 and Sols, A.



(1954)

<I>J. Biol. Chem.</I>
<B>210</B>,
597-606<!-- HIGHWIRE ID="275:29:22381:13" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B14">14.</a>
    <TD VALIGN=TOP>

Passoneau, J. V.,
 and Lauderdale, V. R.



(1974)

<I>Anal. Biochem.</I>
<B>60</B>,
405-412<!-- HIGHWIRE ID="275:29:22381:14" --><A HREF="/cgi/external_ref?access_num=4844560&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=4844560&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B15">15.</a>
    <TD VALIGN=TOP>

Lowry, O. H.,
 and Passoneau, J. V.



(1972)


<I>A Flexible System of Enzymatic Analysis</I>

, Academic Press, New York
    <!-- HIGHWIRE ID="275:29:22381:15" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B16">16.</a>
    <TD VALIGN=TOP>

Furler, S. M.,
Jenkins, A. B.,
Storlien, L. H.,
 and Kraegen, E. W.



(1991)

<I>Am. J.&nbsp;Physiol</I>
<B>261</B>,
E337-E347<!-- HIGHWIRE ID="275:29:22381:16" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=261/3/E337"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B17">17.</a>
    <TD VALIGN=TOP>

Laurent, D.,
Hundal, R. S.,
Dresner, A.,
Price, T. B.,
Vogel, S. M.,
Petersen, K. F.,
 and I., S. G.



(2000)

<I>Am. J.&nbsp;Physiol.</I>
<B>278</B>,
E663-E668<!-- HIGHWIRE ID="275:29:22381:17" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B18">18.</a>
    <TD VALIGN=TOP>

Shulman, G. I.,
Rothman, D. L.,
Jue, T.,
Stein, P.,
DeFronzo, R. A.,
 and Shulman, R. G.



(1990)

<I>N. Engl. J.&nbsp;Med.</I>
<B>322</B>,
223-228<!-- HIGHWIRE ID="275:29:22381:18" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=nejm&resid=322/4/223">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B19">19.</a>
    <TD VALIGN=TOP>

Hansen, P. A.,
Gulve, E. A.,
 and Holloszy, J. O.



(1994)

<I>J. Appl. Physiol.</I>
<B>76</B>,
979-985<!-- HIGHWIRE ID="275:29:22381:19" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jap&resid=76/2/979"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B20">20.</a>
    <TD VALIGN=TOP>

Lombardi, A. M.,
Moller, D.,
Loizeau, M.,
Girard, J.,
 and Leturque, A.



(1997)

<I>FASEB J.</I>
<B>11</B>,
1137-1144<!-- HIGHWIRE ID="275:29:22381:20" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=fasebj&resid=11/13/1137">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B21">21.</a>
    <TD VALIGN=TOP>

Cline, G. W.,
Petersen, K. F.,
Krssak, M.,
Shen, J.,
Hundal, R. S.,
Trajanoski, Z.,
Inzucchi, S.,
Dresner, A.,
Rothman, D. L.,
 and Shulman, G. I.



(1999)

<I>N. Engl. J.&nbsp;Med.</I>
<B>341</B>,
240-246<!-- HIGHWIRE ID="275:29:22381:21" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=nejm&resid=341/4/240"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B22">22.</a>
    <TD VALIGN=TOP>

Wang, W.,
Hansen, P. A.,
Marshall, B. A.,
Holloszy, J. O.,
 and Mueckler, M.



(1996)

<I>J. Cell Biol.</I>
<B>135</B>,
415-430<!-- HIGHWIRE ID="275:29:22381:22" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jcb&resid=135/2/415">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>

</TABLE>



<P><HR>
<FONT SIZE=-1><A HREF="/misc/terms.shtml"><B>Copyright &#169; 2000 by The American Society for Biochemistry and Molecular Biology, Inc.</B></A></FONT>




<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


</vardef>

		
        
        
	
	
	



 




<BR CLEAR=ALL>




<A NAME="otherarticles"><!-- null --></A>
<P>
<FONT SIZE=+2><STRONG>This article has been cited by other articles:</STRONG></FONT>
<P>




<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://ajpendo.physiology.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://ajpendo.physiology.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://ajpendo.physiology.org"><IMG ALT="Am. J. Physiol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/ajpendo.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. O. Holloszy<BR>
	<STRONG>A forty-year memoir of research on the regulation of glucose transport into muscle</STRONG><BR>
	
		
			Am J Physiol Endocrinol Metab,
		
	
        
        March&nbsp;1,&nbsp;2003;
	284(3):
	E453 - 467.
<BR>
<A HREF="http://ajpendo.physiology.org/cgi/content/abstract/284/3/E453">[Abstract]</A>

<A HREF="http://ajpendo.physiology.org/cgi/content/full/284/3/E453">[Full Text]</A>
<A HREF="http://ajpendo.physiology.org/cgi/reprint/284/3/E453">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://ajplung.physiology.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://ajplung.physiology.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://ajplung.physiology.org"><IMG ALT="Am. J. Physiol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/ajplung.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Ahmad, S. Ahmad, B. K. Schneider, C. B. Allen, L.-Y. Chang, and C. W. White<BR>
	<STRONG>Elevated expression of hexokinase II protects human lung epithelial-like A549 cells against oxidative injury</STRONG><BR>
	
		
			Am J Physiol Lung Cell Mol Physiol,
		
	
        
        September&nbsp;1,&nbsp;2002;
	283(3):
	L573 - 584.
<BR>
<A HREF="http://ajplung.physiology.org/cgi/content/abstract/283/3/L573">[Abstract]</A>

<A HREF="http://ajplung.physiology.org/cgi/content/full/283/3/L573">[Full Text]</A>
<A HREF="http://ajplung.physiology.org/cgi/reprint/283/3/L573">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>










<BR CLEAR=ALL>
<BR CLEAR=ALL>


	
	 
		  
			                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/275/29/22381">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/275/29/22381">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;275/29/22381">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/275/29/22381&title=Transgenic+Overexpression+of+Hexokinase+II+in+Skeletal+Muscle+Does+Not+Increase+Glucose+Disposal+in+Wild-type+or+Glut1-overexpressing+Mice">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;M001946200&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=10764781&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=10764781&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Hansen+PA&link_type=AUTHORSEARCH">Hansen, P. A.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Mueckler+M&link_type=AUTHORSEARCH">Mueckler, M.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;275/29/22381&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F275%2F29%2F22381"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;275/29/22381">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx --><!-- 4xxx --><!-- 5xxx -->         
	        <TR><TD ALIGN=LEFT NOWRAP>   <!-- revisions table -->
		

	
	<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
	All Versions of this Article:	
	</FONT></TD></TR>
	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">275/29/22381<FONT COLOR="#A70716"> (most recent)</FONT></FONT></TD></TR>
	         

	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/content/short/M001946200v1">M001946200v1</A></FONT></TD></TR>
	
	</TABLE>
	         

    
		</TD></TR>
        
        
	</TABLE>	 <!-- end of outer content box -->
	


					
	

<BR CLEAR=ALL>

        
	<P>
	<HR NOSHADE ALIGN="LEFT" WIDTH="450" SIZE="1">
	
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol275/issue29/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	
	


	
<TABLE CELLPADDING="2" CELLSPACING="2" BORDER="0">
<TR>
        <TD BGCOLOR="#006699" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.asbmb.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">All ASBMB Journals</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#CC0000" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.mcponline.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Molecular and Cellular Proteomics</A></STRONG>&nbsp;</TD>
</TR><TR>
        <TD BGCOLOR="#0099FF" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.jlr.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Journal of Lipid Research</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#003F77" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.bambed.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Biochemistry and Molecular Biology Education</A></STRONG>&nbsp;</TD>
</TR>
</TABLE>

	<FONT SIZE="-1"><STRONG><A TARGET="_top" HREF="/misc/terms.shtml">Copyright &copy; 2000 by the American Society for Biochemistry and Molecular Biology.</A></STRONG></FONT>
	


</BODY>
</HTML>
